Neurology Minute
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:04:04
- More information
Informações:
Synopsis
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200211
